Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D, Zhang J, Korkmaz B, Chalmers JD, Basso J, Lasala D, Fernandez C, Teper A, Mange KC, Perkins WR, Sullivan EJ. Cipolla D, et al. Among authors: sullivan ej. Respir Res. 2023 May 17;24(1):133. doi: 10.1186/s12931-023-02444-z. Respir Res. 2023. PMID: 37198686 Free PMC article. Clinical Trial.
Identifying a core outcome set for pulmonary sarcoidosis research - the Foundation for Sarcoidosis Research - Sarcoidosis Clinical OUtcomes Taskforce (SCOUT).
Harman NL, Gorst SL, Williamson PR, Barnathan ES, Baughman RP, Judson MA, Junk H, Kampstra NA, Sullivan EJ, Victorson DE, Walton MK, Al-Hakim T, Nabulsi H, Singh N, Grutters JC, Culver DA. Harman NL, et al. Among authors: sullivan ej. Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(3):e2022030. doi: 10.36141/svdld.v39i3.12319. Epub 2022 Sep 23. Sarcoidosis Vasc Diffuse Lung Dis. 2022. PMID: 36791046 Free PMC article.
Scout - sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis.
Harman NL, Gorst SL, Williamson PR, Barnathan ES, Baughman RP, Judson MA, Junk H, Kampstra NA, Sullivan EJ, Victorson DE, Walton M, Al-Hakim T, Nabulsi H, Singh N, Grutters JC, Culver DA. Harman NL, et al. Among authors: sullivan ej. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(3):e2021034. doi: 10.36141/svdld.v38i3.10737. Epub 2021 Sep 30. Sarcoidosis Vasc Diffuse Lung Dis. 2021. PMID: 34744426 Free PMC article.
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
Reed DS, McElroy AK, Barbeau DJ, McMillen CM, Tilston-Lunel NL, Nambulli S, Cottle E, Gilliland TC, Rannulu H, Lundy J, Olsen EL, O'Malley KJ, Xia M, Hartman AL, Luke TC, Egland K, Bausch C, Wu H, Sullivan EJ, Klimstra WB, Duprex WP. Reed DS, et al. Among authors: sullivan ej. PLoS One. 2024 Jun 20;19(6):e0290909. doi: 10.1371/journal.pone.0290909. eCollection 2024. PLoS One. 2024. PMID: 38900732 Free PMC article.
Inducible transposon mutagenesis for genome-scale forward genetics.
Basta DW, Campbell IW, Sullivan EJ, Hotinger JA, Hullahalli K, Waldor MK. Basta DW, et al. Among authors: sullivan ej. bioRxiv [Preprint]. 2024 May 21:2024.05.21.595064. doi: 10.1101/2024.05.21.595064. bioRxiv. 2024. PMID: 38826325 Free PMC article. Preprint.
A fully human monoclonal antibody possesses antibody-dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a conserved epitope at the HA1 protomer interface.
Gao R, Wang Z, Uprety T, Sreenivasan CC, Sheng Z, Hause BM, Brunick C, Wu H, Luke T, Bausch CL, Sullivan EJ, Hoppe AD, Huber VC, Wang D, Li F. Gao R, et al. Among authors: sullivan ej. J Med Virol. 2023 Jul;95(7):e28901. doi: 10.1002/jmv.28901. J Med Virol. 2023. PMID: 37394780
145 results